{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:53:52Z","timestamp":1790405632390,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007184","name":"Yale School of Medicine","doi-asserted-by":"publisher","award":["Yale School of Medicine Medical Student Fellowship"],"award-info":[{"award-number":["Yale School of Medicine Medical Student Fellowship"]}],"id":[{"id":"10.13039\/100007184","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12282-019-00974-3","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T21:11:58Z","timestamp":1558559518000},"page":"719-728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Association between pre-diagnosis BMI, physical activity, pathologic complete response, and chemotherapy completion in women treated with neoadjuvant chemotherapy for breast cancer"],"prefix":"10.1007","volume":"26","author":[{"given":"Ilana","family":"Usiskin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda L.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Cartmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-2597","authenticated-orcid":false,"given":"Tara","family":"Sanft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"974_CR1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/bjc.1998.99","volume":"77","author":"AH Honkoop","year":"1998","unstructured":"Honkoop AH, van Diest PJ, de Jong JS, Linn SC, Giaccone G, Hoekman K, et al. Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer. 1998;77:621\u20136.","journal-title":"Br J Cancer"},{"key":"974_CR2","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1245\/s10434-015-4404-8","volume":"22","author":"P Cortazar","year":"2015","unstructured":"Cortazar P, Geyer CE Jr. Pathological complete response in neoadjuvant treatment of breast cancer. Ann Surg Oncol. 2015;22:1441\u20136.","journal-title":"Ann Surg Oncol"},{"key":"974_CR3","first-page":"790","volume":"14","author":"RL Yung","year":"2016","unstructured":"Yung RL, Ligibel JA. Obesity and breast cancer: risk, outcomes, and future considerations. Clin Adv Hematol Oncol. 2016;14:790\u20137.","journal-title":"Clin Adv Hematol Oncol"},{"key":"974_CR4","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10552-008-9203-0","volume":"19","author":"BJ Caan","year":"2008","unstructured":"Caan BJ, Kwan ML, Hartzell G, Castillo A, Slattery ML, Sternfeld B, et al. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008;19:1319\u201328.","journal-title":"Cancer Causes Control"},{"key":"974_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10549-007-9785-3","volume":"111","author":"B Majed","year":"2008","unstructured":"Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B. Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat. 2008;111:329\u201342.","journal-title":"Breast Cancer Res Treat"},{"key":"974_CR6","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1200\/JCO.2007.14.4527","volume":"26","author":"JK Litton","year":"2008","unstructured":"Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M, et al. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol. 2008;26:4072\u20137.","journal-title":"J Clin Oncol"},{"key":"974_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/cam4.388","volume":"4","author":"J Bao","year":"2015","unstructured":"Bao J, Borja N, Rao M, Huth J, Leitch AM, Rivers A, et al. Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancer. Cancer Med. 2015;4:500\u20136.","journal-title":"Cancer Med"},{"key":"974_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.7150\/jca.10580","volume":"6","author":"T Kogawa","year":"2015","unstructured":"Kogawa T, Fouad TM, Wei C, Masuda H, Kai K, Fujii T, et al. Association of Body Mass index changes during neoadjuvant chemotherapy with pathologic complete response and clinical outcomes in patients with locally advanced breast cancer. J Cancer. 2015;6:310\u20138.","journal-title":"J Cancer"},{"key":"974_CR9","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.clbc.2016.02.018","volume":"16","author":"T Erbes","year":"2016","unstructured":"Erbes T, Stickeler E, Rucker G, Buroh S, Asberger J, Dany N, et al. BMI and pathologic complete response to neoadjuvant chemotherapy in breast cancer: a study and meta-analysis. Clin Breast Cancer. 2016;16:e119\u201332.","journal-title":"Clin Breast Cancer"},{"key":"974_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.breast.2016.05.013","volume":"32","author":"F Karatas","year":"2017","unstructured":"Karatas F, Erdem GU, Sahin S, Aytekin A, Yuce D, Sever AR, et al. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients. Breast. 2017;32:237\u201344.","journal-title":"Breast"},{"key":"974_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ijc.21812","volume":"119","author":"P Pasanisi","year":"2006","unstructured":"Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S. Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer. 2006;119:236\u20138.","journal-title":"Int J Cancer"},{"key":"974_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.clon.2010.02.001","volume":"22","author":"LA Healy","year":"2010","unstructured":"Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, et al. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol). 2010;22:281\u20138.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"974_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/JCO.2009.26.4473","volume":"29","author":"C Duggan","year":"2011","unstructured":"Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, et al. Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol. 2011;29:32\u20139.","journal-title":"J Clin Oncol"},{"key":"974_CR14","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1001\/jama.293.20.2479","volume":"293","author":"MD Holmes","year":"2005","unstructured":"Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293:2479\u201386.","journal-title":"JAMA"},{"key":"974_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10654-014-9916-1","volume":"29","author":"S Zhong","year":"2014","unstructured":"Zhong S, Jiang T, Ma T, Zhang X, Tang J, Chen W, et al. Association between physical activity and mortality in breast cancer: a meta-analysis of cohort studies. Eur J Epidemiol. 2014;29:391\u2013404.","journal-title":"Eur J Epidemiol"},{"key":"974_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/1940-6207.CAPR-10-0295","volume":"4","author":"ML Irwin","year":"2011","unstructured":"Irwin ML, McTiernan A, Manson JE, Thomson CA, Sternfeld B, Stefanick ML, et al. Physical activity and survival in postmenopausal women with breast cancer: results from the women\u2019s health initiative. Cancer Prev Res (Phila). 2011;4:522\u20139.","journal-title":"Cancer Prev Res (Phila)."},{"key":"974_CR17","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/cncr.11227","volume":"97","author":"ML Irwin","year":"2003","unstructured":"Irwin ML, Crumley D, McTiernan A, Bernstein L, Baumgartner R, Gilliland FD, et al. Physical activity levels before and after a diagnosis of breast carcinoma: the health, eating, activity, and lifestyle (HEAL) study. Cancer. 2003;97:1746\u201357.","journal-title":"Cancer"},{"key":"974_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3109\/0284186X.2014.998275","volume":"54","author":"IM Lahart","year":"2015","unstructured":"Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54:635\u201354.","journal-title":"Acta Oncol"},{"key":"974_CR19","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1158\/1055-9965.EPI-09-0538","volume":"18","author":"CN West-Wright","year":"2009","unstructured":"West-Wright CN, Henderson KD, Sullivan-Halley J, Ursin G, Deapen D, Neuhausen S, et al. Long-term and recent recreational physical activity and survival after breast cancer: the California Teachers Study. Cancer Epidemiol Biomarkers Prev. 2009;18:2851\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"974_CR20","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/ijc.28130","volume":"133","author":"ME Schmidt","year":"2013","unstructured":"Schmidt ME, Chang-Claude J, Vrieling A, Seibold P, Heinz J, Obi N, et al. Association of pre-diagnosis physical activity with recurrence and mortality among women with breast cancer. Int J Cancer. 2013;133:1431\u201340.","journal-title":"Int J Cancer"},{"key":"974_CR21","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1200\/JCO.2007.15.9822","volume":"26","author":"ML Irwin","year":"2008","unstructured":"Irwin ML, Smith AW, McTiernan A, Ballard-Barbash R, Cronin K, Gilliland FD, et al. Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol. 2008;26:3958\u201364.","journal-title":"J Clin Oncol"},{"key":"974_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12032-010-9536-x","volume":"28","author":"EM Ibrahim","year":"2011","unstructured":"Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011;28:753\u201365.","journal-title":"Med Oncol"},{"key":"974_CR23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1186\/s12885-015-1971-9","volume":"15","author":"KB Borch","year":"2015","unstructured":"Borch KB, Braaten T, Lund E, Weiderpass E. Physical activity before and after breast cancer diagnosis and survival\u2014the Norwegian women and cancer cohort study. BMC Cancer. 2015;15:967.","journal-title":"BMC Cancer"},{"key":"974_CR24","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/aje\/kwu466","volume":"181","author":"Y Lu","year":"2015","unstructured":"Lu Y, John EM, Sullivan-Halley J, Vigen C, Gomez SL, Kwan ML, et al. History of recreational physical activity and survival after breast cancer: the California breast cancer survivorship consortium. Am J Epidemiol. 2015;181:944\u201355.","journal-title":"Am J Epidemiol"},{"key":"974_CR25","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJM199405053301801","volume":"330","author":"WCBD Wood","year":"1994","unstructured":"Wood WCBD, Wood WCBD, AH WCBD. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med. 1994;330:1253\u20139.","journal-title":"N Engl J Med"},{"key":"974_CR26","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1200\/JCO.2014.59.1081","volume":"33","author":"H van Waart","year":"2015","unstructured":"van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33:1918\u201327.","journal-title":"J Clin Oncol"},{"key":"974_CR27","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American joint committee on cancer the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471\u20134.","journal-title":"Ann Surg Oncol"},{"key":"974_CR28","first-page":"S73","volume":"29","author":"A Kriska","year":"1997","unstructured":"Kriska A. Modifiable activity Questionnaire. Med Sci Sports Exerc. 1997;29:S73\u20138.","journal-title":"Med Sci Sports Exerc"},{"key":"974_CR29","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","volume":"43","author":"BE Ainsworth","year":"2011","unstructured":"Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43:1575\u201381.","journal-title":"Med Sci Sports Exerc"},{"key":"974_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-med-051613-012328","volume":"66","author":"PJ Goodwin","year":"2015","unstructured":"Goodwin PJ, Stambolic V. Impact of the obesity epidemic on cancer. Annu Rev Med. 2015;66:281\u201396.","journal-title":"Annu Rev Med"},{"key":"974_CR31","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1002\/cncr.30104","volume":"122","author":"CM Dieli-Conwright","year":"2016","unstructured":"Dieli-Conwright CM, Wong L, Waliany S, Bernstein L, Salehian B, Mortimer JE. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer. 2016;122:2646\u201353.","journal-title":"Cancer"},{"key":"974_CR32","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/jnci\/90.16.1205","volume":"90","author":"DR Budman","year":"1998","unstructured":"Budman DR, Berry DA, Cirrincione CT, Henderson IC, Wood WC, Weiss RB, et al. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst. 1998;90:1205\u201311.","journal-title":"J Natl Cancer Inst"},{"key":"974_CR33","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.6004\/jnccn.2015.0166","volume":"13","author":"N Denduluri","year":"2015","unstructured":"Denduluri N, Patt DA, Wang Y, Bhor M, Li X, Favret AM, et al. Dose delays, dose reductions, and relative dose intensity in patients with cancer who received adjuvant or neoadjuvant chemotherapy in community oncology practices. J Natl Compr Canc Netw. 2015;13:1383\u201393.","journal-title":"J Natl Compr Canc Netw"},{"key":"974_CR34","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1249\/MSS.0000000000000297","volume":"46","author":"KS Courneya","year":"2014","unstructured":"Courneya KS, Segal RJ, McKenzie DC, Dong H, Gelmon K, Friedenreich CM, et al. Effects of exercise during adjuvant chemotherapy on breast cancer outcomes. Med Sci Sports Exerc. 2014;46:1744\u201351.","journal-title":"Med Sci Sports Exerc"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-019-00974-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-019-00974-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-019-00974-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T23:25:03Z","timestamp":1590017103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-019-00974-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1007\/s12282-019-00974-3","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"1 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This work is supported by the Yale School of Medicine Medical Student Fellowship.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Yale University Human Investigation Committee, protocol number 2000021102, initial approval 6\/14\/2017.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}